Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, India speaks to The Hindu on the COVID-19 pandemic, vaccines, variants and steps we need to take in order to ensure maximum safety, without hampering the economy.
Related Posts
MoU signing with Institute of Bioinformatics and Applied Biotechnology (IBAB)
We are glad to announce an institutional MoU with Institute of Bioinformatics... read more
Anti-microbial resistance – The next pandemic
“Although the link between human anti-microbial use and emergence of resistance is... read more
On the new Covid 19 variant & why surveillance still matters
Wastewater surveillance In times when the viral case load is down and people... read more
Ignoring wastewater is a wasted opportunity to improve disease response
During the COVID-19 pandemic, wastewater surveillance emerged as a valuable tool to... read more
PhD Admissions – Shortlisted candidates for interview
TIGS PhD admissions (Jan 2023) via AcSIR List of shortlisted candidates for interview Click... read more
कोरोना के नए वैरिएंट
टाटा इंस्टीट्यूट फॉर जेनेटिक्स एंड सोसाइटी के निदेशक राकेश मिश्रा का कहना... read more
Talk by Dr. Madhvi Joshi on ‘Learnings from Past: Extending Environmental Surveillance beyond COVID’
We were glad to host Dr. Madhvi Joshi, Scientist and Joint Director,... read more
Indian Academy of Sciences launch symposium for the release of a special issue on the ‘Rare Genetic Diseases Landscape in India’
Recently the Journal of Biosciences, Indian Academy of Sciences held a launch... read more
Wastewater analysis can help predict virus breakout faster
The Tata Institute for Genetics and Society (TIGS) in Bengaluru is standardising... read more